Cancer Drug Maker on the Move - Spectrum Pharmaceutical

Shares of cancer drug maker Spectrum Pharmaceutical (Nasdaq:SPPI) soared 5.88% to $6.84 per share on record revenue growth for the fourth quarter and fiscal year 2010.  Compared to of 2009, fourth quarter product revenue surged 500% while annual product revenue doubled from $28 million to $60 million.  The company already have two drugs on the market that bring in continuous cash flow and still have drug on clinical trials that could add to future growth.  Technical chart also shows bullish signal as both 50 day and 100 day moving average are going up with KD lines still rising.  Do expect the stock to keep rising for the year with more good news coming.